Potential conflict of interest: Nothing to report.
Liver Failure/Cirrhosis/Portal Hypertension
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
Article first published online: 31 JUL 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 60, Issue 6, pages 2008–2016, December 2014
How to Cite
Zhang, X., Harmsen, W. S., Mettler, T. A., Kim, W. R., Roberts, R. O., Therneau, T. M., Roberts, L. R. and Chaiteerakij, R. (2014), Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology, 60: 2008–2016. doi: 10.1002/hep.27199
This work was supported by National Institutes of Health (NIH; grant nos.: CA128633 and CA165076; to L.R.R.), the Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567), the Mayo Clinic Cancer Center (CA15083), and the Mayo Clinic Center for Clinical and Translational Science (NIH/NCRR CTSA grant no.: UL1 TR000135). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
See Editorial on Page 1818
- Issue published online: 24 NOV 2014
- Article first published online: 31 JUL 2014
- Accepted manuscript online: 3 MAY 2014 10:41AM EST
- Manuscript Accepted: 29 APR 2014
- Manuscript Received: 24 JAN 2014
Additional Supporting Information may be found at onlinelibrary.wiley.com/doi/10.1002/hep.27199/suppinfo.
|hep27199-sup-0001-suppinfotbl.pdf||62K||Supplemental Table: Multivariate Cox Proportional Hazards analysis of variables associated with death of cirrhotic patients with diabetes. The model excluded AFP from the analysis because 52 of the 250 patients had missing AFP values.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.